Publications (49) ALMUDENA CROOKE ÁLVAREZ publications

2022

  1. Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  2. Dual-Mode Gold Nanoparticle-Based Method for Early Detection of Acanthamoeba

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  3. Neutrophils and neutrophil extracellular trap components: Emerging biomarkers and therapeutic targets for age-related eye diseases

    Ageing Research Reviews, Vol. 74

  4. Presbyopia: An outstanding and global opportunity for early detection of pre-frailty and frailty states

    Frontiers in Medicine

  5. Therapeutic potential of topical administration of siRNAs against HIF-1α for corneal neovascularization

    Experimental Eye Research, Vol. 219

2021

  1. Impact of contact lens wear on NLRP3 gene expression: Implications for ocular frailty in middle-aged adults

    Experimental Eye Research, Vol. 202

  2. Visual function, ocular surface integrity and symptomatology of a new extended depth-of-focus and a conventional multifocal contact lens

    Contact Lens and Anterior Eye, Vol. 44, Núm. 5

2020

  1. Optimization of a Rabbit Dry Eye Model Induced by Topical Instillation of Benzalkonium Chloride

    Journal of Ophthalmology, Vol. 2020

2019

  1. Effect of Melatonin and Its Analogs on Tear Secretion

    The Journal of pharmacology and experimental therapeutics, Vol. 371, Núm. 1, pp. 186-190

2017

  1. Low expression of CD39 and CD73 genes in centenarians compared with octogenarians

    Immunity and Ageing, Vol. 14, Núm. 1

  2. The role and therapeutic potential of melatonin in age-related ocular diseases

    Journal of Pineal Research, Vol. 63, Núm. 2

  3. Understanding the presence and roles of Ap4A (Diadenosine tetraphosphate) in the eye

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 6, pp. 426-434

2016

  1. The role of dinucleoside polyphosphates on the ocular surface and other eye structures

    Progress in Retinal and Eye Research, Vol. 55, pp. 182-205

2015

  1. Effect of melatonin and analogues on corneal wound healing: Involvement of Mt<inf>2</inf> melatonin receptor

    Current Eye Research, Vol. 40, Núm. 1, pp. 56-65

  2. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells

    Journal of Pharmacology and Experimental Therapeutics, Vol. 352, Núm. 1, pp. 119-128

  3. Signs and symptoms of dry eye in keratoconus patients: A pilot study

    Current Eye Research, Vol. 40, Núm. 11, pp. 1088-1094

2014

  1. An update on dry eye disease molecular treatment: Advances in drug pipelines

    Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 10, pp. 1371-1390

2013

  1. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: Significance for combination therapy in glaucoma

    Journal of Pharmacology and Experimental Therapeutics, Vol. 346, Núm. 1, pp. 138-145

2012

  1. Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT

    Journal of Pineal Research, Vol. 52, Núm. 3, pp. 265-270

  2. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential

    Expert Opinion on Drug Discovery, Vol. 7, Núm. 10, pp. 989-1001